Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Professor Lisa K Stamp

RheumatologistLisa Stamp

MB ChB (Otago) FRACP PhD (Adelaide) DipMus (Auckland)

Email lisa.stamp@cdhb.health.nz

Department of Medicine
University of Otago, Christchurch
P.O. Box 4345
Christchurch
New Zealand

Current Roles

  • Professor in Medicine
  • Rheumatologist

Research Interests

  • Pathophysiology of rheumatoid arthritis
  • Soluble markers in early rheumatoid arthritis
  • Pathophysiology and management of gout
  • Wegener's Granulomatosis 

^ Top of page

Publications

Stamp, L. K., Frampton, C., Drake, J., Doughty, R. N., Troughton, R. W., & Richards, A. M. (2019). Associations of gout and baseline serum urate with cardiovascular outcomes: Analysis of the Coronary Disease Cohort Study. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.41007

Dalbeth, N., Billington, K., Doyle, A., Frampton, C., Tan, P., Allan, J., … Stamp, L. K. (2019). Effects of allopurinol dose escalation on bone erosion and urate volume in gout: A dual energy CT imaging study of a randomized controlled trial. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.40929

Wu, W., Jordan, S., Graf, N., de Oliveira Pena, J., Curram, J., Allanore, Y., … EUSTAR Collaborators, including Stamp, L., Chapman, P., & O'Donnell, J. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. doi: 10.1136/annrheumdis-2018-213455

Bursill, D., Taylor, W. J., Terkeltaub, R., Kuwabara, M., Merriman, T. R., Grainger, R., … Chapman, P. T., … Stamp, L. K., … Dalbeth, N. (2019). Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care & Research, 71(3), 427-434. doi: 10.1002/acr.23607

Stamp, L. K., Anderson, N. G., Becce, F., Rajeswari, M., Polson, M., Guyen, O., … Choi, C., … Raja, A. Y. (2019). Clinical utility of multi-energy spectral photon-counting CT in crystal arthritis [Brief report]. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.40848

Chapter in Book - Research

Dalbeth, N., & Stamp, L. K. (2012). Xanthine oxidase inhibitor treatment of hyperuricemia. In R. Terkeltaub (Ed.), Gout and other crystal arthropathies. (pp. 154-173). Philadelphia, PA: Saunders. doi: 10.1016/B978-1-4377-2864-4.10039-9

Stamp, L. K., & Cleland, L. G. (2008). Foods and rheumatological diseases. In D. D. Metcalfe, H. A. Sampson & R. A. Simon (Eds.), Food allergy: Adverse reactions to foods and food additives. (4th ed.) (pp. 563-574). Malden, MA: Blackwell.

Stamp, L. K., & Cleland, L. G. (2008). Rheumatoid arthritis. In L. U. Thompson & W. E. Ward (Eds.), Optimizing women's health through nutrition. (pp. 279-320). Boca Raton, FL: CRC Press.

Stamp, L. (2008). Gout. In W. Horobin (Ed.), Diseases and disorders: Emphysema-Obesity (Vol. 2). (pp. 385). Tarrytown, NY: Marshall Cavendish.

^ Top of page

Journal - Research Article

Stamp, L. K., Frampton, C., Drake, J., Doughty, R. N., Troughton, R. W., & Richards, A. M. (2019). Associations of gout and baseline serum urate with cardiovascular outcomes: Analysis of the Coronary Disease Cohort Study. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.41007

Bursill, D., Taylor, W. J., Terkeltaub, R., Kuwabara, M., Merriman, T. R., Grainger, R., … Chapman, P. T., … Stamp, L. K., … Dalbeth, N. (2019). Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout. Arthritis Care & Research, 71(3), 427-434. doi: 10.1002/acr.23607

Wu, W., Jordan, S., Graf, N., de Oliveira Pena, J., Curram, J., Allanore, Y., … EUSTAR Collaborators, including Stamp, L., Chapman, P., & O'Donnell, J. (2019). Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Annals of the Rheumatic Diseases, 78(5), 648-656. doi: 10.1136/annrheumdis-2018-213455

Dalbeth, N., Billington, K., Doyle, A., Frampton, C., Tan, P., Allan, J., … Stamp, L. K. (2019). Effects of allopurinol dose escalation on bone erosion and urate volume in gout: A dual energy CT imaging study of a randomized controlled trial. Arthritis & Rheumatology. Advance online publication. doi: 10.1002/art.40929

Turner, R., Brennan, S. O., Ashby, L. V., Dickerhof, N., Hamzah, M. R., Pearson, J. F., Stamp, L. K., & Kettle, A. J. (2018). Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation. Journal of Biological Chemistry. Advance online publication. doi: 10.1074/jbc.RA118.005237

Ton, K. N., Cree, S. L., Gronert-Sum, S. J., Merriman, T. R., Stamp, L. K., & Kennedy, M. A. (2018). Multiplexed nanopore sequencing of HLA-B locus in Māori and Pacific Island samples. Frontiers in Genetics. Advance online publication. doi: 10.3389/fgene.2018.00152

Stamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2018). How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose. Arthritis Research & Therapy, 20, 255. doi: 10.1186/s13075-018-1755-0

Gath, M. E., Stamp, L. K., Aimer, P., Stebbings, S., & Treharne, G. J. (2018). Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators. Musculoskeletal Care, 16(1), 139-146. doi: 10.1002/msc.1227

Gosling, A. L., Boocock, J., Dalbeth, N., Harré Hindmarsh, J., Stamp, L. K., Stahl, E. A., … Matisoo-Smith, E. A., & Merriman, T. R. (2018). Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand. Annals of the Rheumatic Diseases, 77(4), 571-578. doi: 10.1136/annrheumdis-2017-212416

Wright, D. F. B., Dalbeth, N., Phipps-Green, A. J., Merriman, T. R., Barclay, M. L., Drake, J., … Stamp, L. K. (2018). The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool. British Journal of Clinical Pharmacology, 84(5), 937-943. doi: 10.1111/bcp.13516

Aimer, P., Stamp, L. K., Stebbings, S., Cameron, V., Kirby, S., & Treharne, G. J. (2018). Exploring perceptions of a rheumatoid arthritis-specific smoking cessation programme. Musculoskeletal Care, 16, 74-81. doi: 10.1002/msc.1209

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2018). Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial. Rheumatology, 57(12), 2183-2189. doi: 10.1093/rheumatology/key237

Dalbeth, N., Pool, B., Chhana, A., Lin, J.-M., Tay, M. L., Tan, P., … Stamp, L. K., & Cornish, J. (2018). Lack of evidence that soluble urate directly influences bone remodelling: A laboratory and clinical study. Calcified Tissue International, 102(1), 73-84. doi: 10.1007/s00223-017-0328-6

Fatima, T., McKinney, C., Major, T. J., Stamp, L. K., Dalbeth, N., Iverson, C., Merriman, T. R., & Miner, J. N. (2018). The relationship between ferritin and urate levels and risk of gout. Arthritis Research & Therapy, 20, 179. doi: 10.1186/s13075-018-1668-y

Roberts, R. L., Wallace, M. C., Harrison, A. A., White, D., Dalbeth, N., Stamp, L. K., … Highton, J., Merriman, T. R., … Stebbings, S. M. (2018). Association of Crohn's disease-related chromosome 1q32 with ankylosing spondylitis is independent of bowel symptoms and faecal calprotectin. PeerJ, 6, e5088. doi: 10.7717/peerj.5088

Krishnan, M., Major, T. J., Topless, R. K., Dewes, O., Yu, L., Thompson, J. M. D., … Stamp, L. K., … Wilcox, P., Grattan, D., … Merriman, T. R. (2018). Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Māori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia. Advance online publication. doi: 10.1007/s00125-018-4623-1

McKelvey, K. J., Millier, M. J., Doyle, T. C., Stamp, L. K., Highton, J., & Hessian, P. A. (2018). Co-expression of CD21L and IL17A defines a subset of rheumatoid synovia, characterised by large lymphoid aggregates and high inflammation. PLoS ONE, 13(8), e0202135. doi: 10.1371/journal.pone.0202135

Fanning, N., Merriman, T. R., Dalbeth, N., & Stamp, L. K. (2018). An association of smoking with serum urate and gout: A health paradox. Seminars in Arthritis & Rheumatism, 47(6), 825-842. doi: 10.1016/j.semarthrit.2017.11.004

Rolston, C. J., Conner, T. S., Stamp, L. K., Neha, T., Pitama, S., Fanning, N., … Hudson, B., Hegarty, R. M., & Treharne, G. J. (2018). Improving gout education from patients’ perspectives: A focus group study of Māori and Pākehā people with gout. Journal of Primary Health Care, 10(3), 194-200. doi: 10.1071/HC18010

Barclay, M. L., Karim, S., Helms, E. T. J., Keating, P. E., Hock, B., Stamp, L. K., & Schultz, M. (2018). Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.14064

Treharne, G. J., Richardson, A. C., Neha, T., Fanning, N., Janes, R., Hudson, B., … Pitama, S., & Stamp, L. K. (2018). Education preferences of people with gout: Exploring differences between indigenous and non-indigenous peoples from rural and urban locations. Arthritis Care & Research, 70(2), 260-267. doi: 10.1002/acr.23272

Yeo, E., Palmer, S. C., Chapman, P. T., Frampton, C., & Stamp, L. K. (2018). Serum urate levels and therapy in adults treated with long-term dialysis: A retrospective cross-sectional study. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.14163

Stamp, L., Morillon, M. B., Taylor, W. J., Dalbeth, N., Singh, J. A., Lassere, M., & Christensen, R. (2018). Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis. Seminars in Arthritis & Rheumatism, 48(2), 293-301. doi: 10.1016/j.semarthrit.2018.02.009

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: A post hoc analysis of a randomized controlled trial. Arthritis Research & Therapy, 19(1), 283. doi: 10.1186/s13075-017-1491-x

Tanner, C., Boocock, J., Stahl, E. A., Dobbyn, A., Mandal, A. K., Cadzow, M., Phipps-Green, A. J., Topless, R. K., … Stamp, L. K., … Merriman, T. R. (2017). Population specific resequencing associates the ATP binding cassette subfamily C member 4 (ABCC4) gene with gout in New Zealand Māori and Pacific men. Arthritis & Rheumatology, 69(7), 1461-1469. doi: 10.1002/art.40110

Kannangara, D. R. W., Graham, G. G., Wright, D. F. B., Stocker, S. L., Portek, I., Pile, K. D., Barclay, M. L., … Stamp, L. K., & Day, R. O. (2017). Individualising the dose of allopurinol in patients with gout. British Journal of Clinical Pharmacology, 83(9), 2015-2026. doi: 10.1111/bcp.13307

Ogdie, A., Taylor, W. J., Neogi, T., Fransen, J., Jansen, T. L., Schumacher, H. R., … Stamp, L. K., … Dalbeth, N. (2017). Performance of ultrasound in the diagnosis of gout in a multicenter study: Comparison with monosodium urate monohydrate crystal analysis as the gold standard. Arthritis & Rheumatology, 69(2), 429-438. doi: 10.1002/art.39959

Muniraj, N., Stamp, L. K., Badiei, A., Hegde, A., Cameron, V., & Bhatia, M. (2017). Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease. International Journal of Rheumatic Diseases, 20(2), 182-189. doi: 10.1111/1756-185x.12472

Aimer, P., Treharne, G. J., Stebbings, S., Frampton, C., Cameron, V., Kirby, S., & Stamp, L. K. (2017). Efficacy of a rheumatoid arthritis-specific smoking cessation programme: A pilot randomized controlled trial. Arthritis Care & Research, 69(1), 28-37. doi: 10.1002/acr.22960

McQueen, F. M., Chapman, P., Pollock, T., D’Souza, D., Lee, A. C., Dalbeth, N., Stamp, L., … Doyle, A. (2017). Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis. Arthritis Research & Therapy, 19, 241. doi: 10.1186/s13075-017-1433-7

Rasheed, H., Stamp, L. K., Dalbeth, N., & Merriman, T. R. (2017). Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Arthritis Research & Therapy, 19, 161. doi: 10.1186/s13075-017-1369-y

Dalbeth, N., Allan, J., Gamble, G. D., Phipps-Green, A., Flynn, T. J., Mihov, B., … Stamp, L. K., & Merriman, T. R. (2017). Influence of genetic variants on renal uric acid handling in response to frusemide: An acute intervention study. RMD Open, 3(1), e000424. doi: 10.1136/rmdopen-2016-000424

Stamp, L. K., Chapman, P. T., Barclay, M. L., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout. Annals of the Rheumatic Diseases, 76(9), 1522-1528. doi: 10.1136/annrheumdis-2016-210872

Houlder, E. L., Millier, M. J., Highton, J., Gwynne-Jones, D., Stamp, L. K., & Hessian, P. A. (2017). Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. Clinical & Experimental Rheumatology, 35(6), 943-947.

Cleophas, M. C., Joosten, L. A., Stamp, L. K., Dalbeth, N., Woodward, O. M., & Merriman, T. R. (2017). ABCG2 polymorphisms in gout: Insights into disease susceptibility and treatment approaches. Pharmacogenomics & Personalized Medicine, 10, 129-142. doi: 10.2147/pgpm.s105854

Stamp, L. K., Haslett, J., Chapman, P., O'Donnell, J., Raja, R., Rothwell, A., Frampton, C., & Hooper, G. (2017). Rates of joint replacement surgery in New Zealand, 1999-2015: A comparison of rheumatoid arthritis and osteoarthritis. Journal of Rheumatology, 44(12), 1823-1827. doi: 10.3899/jrheum.170551

Wright, S., Chapman, P. T., Frampton, C., O'Donnell, J. L., Raja, R., & Stamp, L. K. (2017). Management of gout in a hospital setting: A lost opportunity. Journal of Rheumatology, 44(10), 1493-1498. doi: 10.3899/jrheum.170387

Batt, C., Fanning, N., Drake, J., Frampton, C., Gearry, R. B., & Stamp, L. K. (2017). Fructose malabsorption in people with and without gout: A case-control study. Seminars in Arthritis & Rheumatism, 47(2), 257-263. doi: 10.1016/j.semarthrit.2017.03.018

Farquhar, H. J., McGettigan, B., Chapman, P. T., O'Donnell, J. L., Frampton, C., & Stamp, L. K. (2017). Incidence of anti-neutrophil cytoplasmic antibody-associated vasculitis before and after the February 2011 Christchurch Earthquake. Internal Medicine Journal, 47(1), 57-61. doi: 10.1111/imj.13246

Stamp, L. K., Morillon, M. B., Taylor, W. J., Dalbeth, N., Singh, J. A., Lassere, M., & Christensen, R. (2017). Variability in the reporting of serum urate and flares in gout clinical trials: Need for minimum reporting requirements. Journal of Rheumatology, 45(3), 170911. doi: 10.3899/jrheum.170911

He, W., Phipps-Green, A., Stamp, L. K., Merriman, T. R., & Dalbeth, N. (2017). Population-specific association between ABCG2 variants and tophaceous disease in people with gout. Arthritis Research & Therapy, 19(1), 43. doi: 10.1186/s13075-017-1254-8

Stamp, L. K., Chapman, P. T., Barclay, M., Horne, A., Frampton, C., Tan, P., … Dalbeth, N. (2017). Allopurinol dose escalation to achieve serum urate below 6 mg/dL: An open-label extension study. Annals of the Rheumatic Diseases, 76(12), 2065-2070. doi: 10.1136/annrheumdis-2017-211873

Vazirpanah, N., Kienhorst, L. B. E., Van Lochem, E., Wichers, C., Rossato, M., Shiels, P. G., … Stamp, L. K., Merriman, T. R., … Broen, J. C. A. (2017). Patients with gout have short telomeres compared with healthy participants: Association of telomere length with flare frequency and cardiovascular disease in gout. Annals of the Rheumatic Diseases, 76(7), 1309-1315. doi: 10.1136/annrheumdis-2016-210538

Nakayama, A., Nakaoka, H., Yamamoto, K., Sakiyama, M., Shaukat, A., Toyoda, Y., … Stamp, L. K., … Merriman, T. R., & Matsuo, H. (2017). GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. Annals of the Rheumatic Diseases, 76(5), 869-877. doi: 10.1136/annrheumdis-2016-209632

Stamp, L., & Dalbeth, N. (2017). Urate-lowering therapy for asymptomatic hyperuricaemia: A need for caution. Seminars in Arthritis & Rheumatism, 46(4), 457-464. doi: 10.1016/j.semarthrit.2016.07.015

Millier, M. J., Stamp, L. K., & Hessian, P. A. (2017). Digital-PCR for gene expression: Impact from inherent tissue RNA degradation. Scientific Reports, 7, 17235 . doi: 10.1038/s41598-017-17619-0

More publications...